idh inhibitors in idh mutant low grade and high grade gliomas: a review of current data
Published 3 years ago • 1K plays • Length 4:41Download video MP4
Download video MP3
Similar videos
-
2:23
vorasidenib in idh-mutant glioma | nejm
-
2:28
targeted therapy for idh1 mutant low-grade glioma
-
6:08
updated results of vorasidenib for idh1/2 mutant glioma
-
11:10
targeting idh mutations in glioma: implications of new data
-
8:13
an evidence-based approach to idh mutated high-risk low-grade glioma
-
7:57
62. glioblastoma versus astrocytoma idh-mutant grade 4; gbm, prognosis different, tme immunotherapy
-
9:07
tip-125;low-grade astrocytoma
-
1:33:59
imaging of brain tumors (part 1): metastases, glioblastoma and beyond...
-
1:21
addressing treatment options for idh-mutant gliomas
-
5:14
olutasidenib for relapsed/refractory idh1 mutant glioma
-
1:46
anti-idh 1 vaccine among patients with low-grade glioma
-
4:46
idh-specific vaccine for high-grade gliomas
-
1:37
bay 2402234 for idh-mutant gliomas newest medical treatement to glioma type iii part
-
1:06
indigo: clinical benefit of vorasidenib in patients with grade 2 idh-mutant glioma
-
2:05
idh inhibitors for cholangiocarcinoma
-
1:14
the impact of idh mutations in mds & evaluating the role of idh inhibitors
-
2:53
the prognostic impact of idh mutations and the role of idh inhibitors in mds
-
1:36
idh mutations in cancer
-
1:01
tim aitman: investigating structural variants in undiagnosed genetic diseases
-
0:30
a synthesis of emerging evidence in ibd
-
5:16
idh1 mutation, histology, and treatment of tissue metabolites in diffuse glioma
-
15:56
idh - mutant astrocytoma: update from the 5th edition who classification of cns tumors